Plus: FDA Updates on Predetermined Change Control Plans ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View in browser
Johner Institute

Medical Device Briefings

Issue 35/26

Develop Your AI-Strategy in One Day

Dear there,

Last week, medical device and IVD manufacturers—from startups to large corporations—met in Konstanz to develop their AI strategies. In today’s Executive Corner, I’ll share the method we used.

Regulatory Updates

a. EU

Update to the GeDIG Report

First, I’d like to thank Dr. Malte Schmieding. In response to my update on the German Act on Data and Digital Innovation in Healthcare (GeDIG), he points out that:

  • The current version of Section 303e(2)(9) of the German Social Code, Book V (SGB V) already explicitly permits the use of data from the Health Data Lab to develop and monitor the safety of medical devices, including AI development.

  • The amendment primarily changes the terminology from “artificial intelligence systems” to “AI models and AI systems,” aligning it with the terminology used in the EU AI Act and Book X of the German Social Code (SGB X).

The message for manufacturers is clear: you don’t need to wait for the GeDIG to collect data for post-market surveillance through this route. And you shouldn’t wait, either.

 

Further Details on the EHDS

We’re staying with the topic of health data. The European Commission has published two draft documents on the European Health Data Space (EHDS).

  1. Draft implementing regulation (5 pages): The draft implementing regulation requires applicants and health data access bodies to use standardized templates for the health data access application, data permit and health data request. These cover applications for data access (Article 67), data permits (Article 68), and requests for purely anonymized statistical results (Article 69).

  2. Annex (59 pages): This document contains the actual templates:

    • Annex I: Application for data access

    • Annex II: Data permit

    • Annex III: Request for statistical results

Anyone applying for data—for example, a manufacturer seeking to train an AI model—must describe, among other things, the purpose, datasets, risks and safeguards, and the secure processing environment.

 

Important: Applications will be made public! There are, however, exceptions for trade secrets and intellectual property. The regulation will not apply until March 2029.

 

b. USA/FDA

Since last week, the FDA has been bringing together the latest information on Predetermined Change Control Plans (PCCPs) on its website.

Can you already anticipate changes to your products, and would you like to avoid having to obtain a new marketing authorization? If so, I recommend taking a closer look at this approach: Plan changes in advance and obtain FDA clearance for them before implementation.

The FDA already lists around 240 products for which it has approved a PCCP, ranging from Apple’s heart rhythm feature to PCR tests.

A PCCP requires three things:

    • A robust quality management system
    • Clearly specified changes
    • Predetermined test methods with acceptance criteria

My tip: Limit the scope to a few changes that can be readily validated, and discuss your PCCP with the FDA early through a Q-Submission. We can help you with this.

Executive Corner: Developing an AI-Strategy in One Day

In the last issue of the Medical Device Briefing, I shared tips on how to introduce AI from the bottom up when “the top” provides no direction—or no useful direction.

This week, I’d like to offer executives some ideas on how to define and implement an AI strategy for their area of responsibility.

Last week, participants in the grand finale of our AI Lab had the exclusive opportunity to develop their AI strategies with us. We’re now opening up access to this knowledge and these methods to all manufacturers, service providers, and Notified Bodies.

Find more info on the methods we use here. Feel free to adopt anything you find useful.

 

We can support you with this task if you:

  • don’t want to prepare your AI strategy day yourself;

  • would value an external, impartial perspective; and

  • want to be confident that you can get started with a clear roadmap, including the necessary decisions, assigned responsibilities, tasks, and deadlines.

Find out more about our AI Strategy Day.

    Practical Tips

    a. Ask AI Where You Could Improve

    I couldn’t resist trying this: in his YouTube Short, Nate B. Jones suggested asking AI how intelligent you are. He argued that the interesting part isn’t the result itself, but the reasoning behind it.

    “Tell me how intelligent I am in terms of percentile. What’s my IQ percentile, based on your interactions with others and what you’ve observed about me?”

    I had to try it myself! I used an extended conversation with my AI about IEC 62366-3, since the AI needs a basis for its assessment.

    It evaluated me against five criteria. Among them were “abstraction discipline” and “epistemic flexibility.” If the latter term is new to you (it certainly was to me), it means having “zero ego defense when confronted with your own mistakes.”

    Now for the results that mattered more to me: I asked the AI where I could improve. Among other things, it recommended that I look into the “curse of knowledge” and become more aware of the consequences of the “authority bias trap.” Ouch!

    Since then, I’ve been asking the AI for advice on how to turn this new awareness into action. Hopefully, you’ll be able to follow my progress here in the Journal. 🙂

     

    My tip: If you’d like a generative AI to assess your potential for growth, ask it to do so based on a conversation in which you’ve worked through a new topic or a complex document together.

     

    b. How to Use AI Even When IT Isn’t Ready Yet

    At two of the 50 companies taking part in my “Zero to Hero” program, IT hadn’t approved the use of the AI tool in time—or at all. This was despite the provider’s contractual commitment not to use the data for training. We weren’t even working with confidential data, just a sample case file.

    So what can you do? I came up with a workaround that IT was happy to approve. If your company hasn’t given you access to a powerful AI model yet, you can use this fallback option, too:

     

    My tip: Arrange access to a virtual Windows machine via DaaS (Desktop as a Service)—essentially, a computer that “runs in your browser”—and work in this separate environment.

     

    We also provide the same secure infrastructure to everyone taking part in our Zero to Hero on demand program. Over seven weeks, you’ll build your own Technical Documentation review system. It’s like paint-by-numbers—no IT or AI expertise required.

    The best way to find out how the program works is to read more here.

    With kind regards,

    Christian

    Founder Johner Institute

     

    P. S. You’ll find a new job posting and a jobseeker’s listing here.

    Upcoming Seminars

    IEC 60601-1 Safety of Medical Electrical Equipment

    November 10-11, 2026

    Learn how to successfully implement the requirements of the IEC 60601 family of standards in practice and ensure standard-compliant documentation.

    In this seminar, you will get all the knowledge to speak to investi­gators and auditors on an equal footing. You will develop a comprehensive understanding of the basic concepts of the IEC 60601 family of standards, and learn how to successfully imple­ment the relevant requirements in practice using various exercises and how to create standard-compliant documentation.

     

    Sign up here

     

    AI Power for Medical Device Development and Approval – Practical Workshop 

    April 27-28, 2027

    Learn in just two (half) days how to use large language models (LLMs) specifically in developing medical devices – from the initial idea to post-market surveillance. This practical workshop will teach you specific methods that will enable you to drastically reduce the time needed to develop and document your medical devices while remaining compliant with the law.

     

    Sign up here

    Support from the Johner Institute

    The Johner Institute's Product & Service Portfolio

     

    The Johner Institute supports the medical device ecosystem (manufacturers, authorities, notified bodies, operators) in all regulatory challenges.

    • Strategic Consulting
      e.g., regulatory and clinical strategies for global device approval, quality systems, technical documentation, artificial intelligence
    • Business Process Outsourcing
      e.g., regulatory monitoring, post-market surveillance, clinical evaluation
    • Software (Enterprise SaaS)
      e.g., for regulatory monitoring, post-market surveillance
    • Product Testing
      e.g., clinical investigations, usability tests, pentesting, biocompatibility tests
    • Training
      e.g., seminars and e-learning
    • Taking on Regulatory Roles
      e.g., QM representative, legal manufacturer, in-country representation

    Prof. Dr. Christian Johner

     

    Johner Institut GmbH

    Reichenaustr. 39a

    78467 Konstanz

     

     

    +49 (0) 7531 94500 20 
    info@johner-institute.com
    www.johner-institute.com

    Privacy Policy   |   Subscription Settings

    Johner Institut GmbH, Reichenaustr. 39a, Konstanz, Baden-Württemberg 78467, Deutschland

    Manage preferences